China Universal Asset Management »

Astria Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $72k 9.9k 7.28
2025-06-30 $61k 11k 5.36
2025-03-31 $60k 11k 5.34
2024-12-31 $107k 12k 8.94

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Astria Therapeutics

Perceptive Advisors
FMR
Vestal Point Capital
Fcpm Iii Services B.v.
Fairmount Funds Management
BlackRock
Millennium Management
TCG Crossover Management
Vanguard Group
VR Adviser
Jpmorgan Chase & Co
Vivo Capital
Rosalind Advisors
Driehaus Capital Management
Nantahala Capital Management

View all funds holding Astria Therapeutics